RSS Parrot

BETA

🦜 The Lancet

@www.thelancet.com.journals.lancet.issue.current@rss-parrot.net

I'm an automated parrot! I relay a website's RSS feed to the Fediverse. Every time a new post appears in the feed, I toot about it. Follow me to get all new posts in your Mastodon timeline! Brought to you by the RSS Parrot.

---

The Lancet RSS feed.

Your feed and you don't want it here? Just e-mail the birb.

Site URL: www.thelancet.com/journals/lancet/issue/current

Feed URL: www.thelancet.com/rssfeed/lancet_current.xml

Posts: 41

Followers: 3

[Correspondence] Agatha Christie: medicine, diagnosis, and the art of detection

Published: November 21, 2026 00:00

2026 marks the 50th anniversary of the death of Agatha Christie (1890–1976). This occasion offers an opportunity to look again at Christie not only as a central figure in the history of crime fiction, but also as an author whose work shows a sustained and…

[Perspectives] Monica Geingos: advocate for adolescent health joins PMNCH

Published: November 21, 2026 00:00

“Sexual and reproductive health and rights [SRHR] have been under a constant and coordinated attack”, notes Monica Geingos, former First Lady of Namibia, UNAIDS Special Ambassador for Adolescent Sexual and Reproductive Health and Rights, and Co-Chair of…

[Correspondence] Defining success in kidney xenotransplantation – Authors' reply

Published: November 21, 2026 00:00

We thank Christopher H Kim and colleagues for their thoughtful comments and agree that success in kidney xenotransplantation should ultimately extend beyond graft survival or dialysis independence alone. Their Correspondence highlights an important…

[Comment] Retraction: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

Published: November 21, 2026 00:00

On Feb 3, 2026, The Lancet published an Expression of Concern1 for a 2006 Case Report by Gideon Koren and colleagues,2 having received new allegations of falsification of toxicological data, authorship issues, and ethical concerns. These new allegations…

[Comment] Sacituzumab tirumotecan in previously treated endometrial cancer

Published: November 21, 2026 00:00

Endometrial cancer is the most common gynaecological cancer in high-income countries, the sixth most common cancer in women worldwide,1 and one of few cancers for which both the incidence and mortality rate are increasing.2,3 Although 75% of endometrial…

[Correspondence] The F-words for Child Development: Lessons Learned

Published: November 21, 2026 00:00

We write as the creators and promoters of the F-words for Child Development framework1 to thank Chloe Wilson and colleagues for their refreshing advocacy of this expanded set of ideas regarding disability.2 Not surprisingly, we agree with and fully endorse…

[Correspondence] The Lancet Group's guidance on reporting disability: make link to the ICF explicit

Published: November 21, 2026 00:00

The Lancet Group's new guidance on reporting disability1 is an important step towards more inclusive health research. However, we believe that one crucial link is missing: WHO's International Classification of Functioning, Disability and Health (ICF).2

[Comment] Remibrutinib: a high-efficacy disease-modifying drug for relapsing multiple sclerosis?

Published: November 21, 2026 00:00

Bruton's tyrosine kinase (BTK) inhibitors directly modulate the functions of B lymphocytes and myeloid cells (notably macrophages and microglia) and thus target both the adaptive and innate mechanisms that contribute to the immunopathology of multiple…

[Comment] Expanding the post-EGFR TKI landscape with antibody–drug conjugates

Published: November 21, 2026 00:00

Third-generation EGFR tyrosine kinase inhibitors (TKIs), increasingly combined with chemotherapy or amivantamab, are the preferred front-line treatment for EGFR-mutant non-small-cell lung cancer (NSCLC).1,2 With actionable resistance mechanisms often…

[Correspondence] Evidence and gaps for preventing postpartum haemorrhage

Published: November 14, 2026 00:00

The claim by Ioannis D Gallos and colleagues that tranexamic acid does not have a preventive role does not reflect the scientific evidence.1 The Sustainable Development Goal is to reduce the maternal mortality ratio to fewer than 70 per 100 000 livebirths…

[Comment] Empirical tuberculosis treatment in infants living with HIV: missed opportunities and ways to improve outcomes

Published: November 14, 2026 00:00

Pneumonia remains the leading cause of death among infants living with HIV, with the case-fatality rate approaching 40%.1 Improving outcomes for these vulnerable infants demands new diagnostic and therapeutic approaches, yet current WHO guidelines for…

[Correspondence] The Perth Declaration to eliminate rheumatic fever and rheumatic heart disease

Published: November 14, 2026 00:00

The persistence of rheumatic heart disease reveals how profoundly social inequity can shape who benefits from medical progress. Approximately 55 million people live with the disease, and more than 370 000 die each year.1 It is the most common acquired…

[Perspectives] Lalitha Regi and Regi George: strengthening community health

Published: November 14, 2026 00:00

Working as doctors in a rural hospital in Tamil Nadu, India, married couple Lalitha Regi and Regi George realised that clinical care alone would not solve their patients’ health problems. The hospital “was a bottomless pit that you are just feeding and…

[Correspondence] Evidence and gaps for preventing postpartum haemorrhage

Published: November 14, 2026 00:00

We congratulate Arri Coomarasamy and colleagues for an excellent Series on postpartum haemorrhage (PPH),1–3 which provides an important evidence-based framework for improving maternal outcomes worldwide. We fully support the authors’ comprehensive approach…

[Correspondence] Evidence and gaps for preventing postpartum haemorrhage – Authors’ reply

Published: November 14, 2026 00:00

We thank Judith Lieber and colleagues and Gabriele Saccone and colleagues for their responses to our Series. Lieber and colleagues’ comment highlights the importance of distinguishing evidence for prevention from evidence for treatment. We agree with them…

[Comment] Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?

Published: November 14, 2026 00:00

Around a quarter of advanced or recurrent endometrial carcinomas are mismatch repair deficient (dMMR).1 Addition of a PD-1 or PD-L1 inhibitor to carboplatin plus paclitaxel has transformed first-line treatment for this subgroup, with the RUBY,1 NRG-GY018,2…

[Articles] Empirical tuberculosis treatment in infants living with HIV hospitalised with severe pneumonia in Africa (EMPIRICAL): a multicentre, randomised, open-label, 2 × 2 factorial, controlled superiority trial

Published: November 14, 2026 00:00

In contrast to empirical treatment with valganciclovir, there was no evidence that eTB-T was superior to a clinically and microbiologically guided strategy in reducing all-cause mortality among infants with HIV-associated pneumonia. However, the high…